# Takeda Pharmaceutical Co Ltd: insider transactions

SEC CIK 1395064. Roles and transactions as reported on Form 4. Latest Form 4 filed 2024-01-25.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | 10% owner | 55 | 2021-05-03 | 2024-01-24 |

## Transactions: 55

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2024-01-24 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 3,703,703 | $8.10 | $30.0m | [Form 4](/filings/0001395064-24-000008.md) |
| 2022-03-14 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Option exercise (in the money) (X), derivative | 7,359,304 | $0.00 | $0 | [Form 4](/filings/0001395064-22-000040.md) |
| 2022-03-14 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 18 | $19.00 | $342 | [Form 4](/filings/0001395064-22-000040.md) |
| 2022-03-14 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Option exercise (in the money) (X) | 7,359,304 | $0.00 | $0 | [Form 4](/filings/0001395064-22-000040.md) |
| 2021-11-04 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Option exercise (in the money) (X), derivative | 228,696 | $0.00 | $0 | [Form 4](/filings/0001395064-21-000231.md) |
| 2021-11-04 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 1,000,000 | $20.85 | $20.9m | [Form 4](/filings/0001395064-21-000231.md) |
| 2021-11-04 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 1 | $19.00 | $19 | [Form 4](/filings/0001395064-21-000231.md) |
| 2021-11-04 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Option exercise (in the money) (X) | 228,696 | $0.00 | $0 | [Form 4](/filings/0001395064-21-000231.md) |
| 2021-07-07 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 2,609 | $35.05 | $91.4k | [Form 4](/filings/0001395064-21-000153.md) |
| 2021-07-02 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 100 | $35.01 | $3.5k | [Form 4](/filings/0001395064-21-000148.md) |
| 2021-07-01 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 8,226 | $35.16 | $289.2k | [Form 4](/filings/0001395064-21-000148.md) |
| 2021-06-28 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 370 | $35.08 | $13.0k | [Form 4](/filings/0001395064-21-000142.md) |
| 2021-06-25 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 1,250 | $36.07 | $45.1k | [Form 4](/filings/0001395064-21-000142.md) |
| 2021-06-25 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 22,881 | $35.46 | $811.4k | [Form 4](/filings/0001395064-21-000142.md) |
| 2021-06-24 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 10,848 | $35.14 | $381.2k | [Form 4](/filings/0001395064-21-000125.md) |
| 2021-06-23 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 200 | $35.00 | $7.0k | [Form 4](/filings/0001395064-21-000125.md) |
| 2021-06-22 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 100 | $35.00 | $3.5k | [Form 4](/filings/0001395064-21-000121.md) |
| 2021-06-21 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 9,294 | $35.31 | $328.2k | [Form 4](/filings/0001395064-21-000121.md) |
| 2021-06-18 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 5,398 | $35.13 | $189.6k | [Form 4](/filings/0001395064-21-000119.md) |
| 2021-06-17 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 3,305 | $35.08 | $115.9k | [Form 4](/filings/0001395064-21-000119.md) |
| 2021-06-14 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 2,826 | $35.06 | $99.1k | [Form 4](/filings/0001395064-21-000113.md) |
| 2021-06-10 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 2,102 | $35.14 | $73.9k | [Form 4](/filings/0001395064-21-000111.md) |
| 2021-06-09 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 1,191 | $35.28 | $42.0k | [Form 4](/filings/0001395064-21-000111.md) |
| 2021-06-08 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 100 | $35.00 | $3.5k | [Form 4](/filings/0001395064-21-000109.md) |
| 2021-06-07 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 2,264 | $35.05 | $79.4k | [Form 4](/filings/0001395064-21-000109.md) |
| 2021-06-02 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 4,300 | $35.18 | $151.3k | [Form 4](/filings/0001395064-21-000107.md) |
| 2021-06-01 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 3,967 | $36.20 | $143.6k | [Form 4](/filings/0001395064-21-000105.md) |
| 2021-06-01 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 7,244 | $35.55 | $257.5k | [Form 4](/filings/0001395064-21-000105.md) |
| 2021-05-28 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 2,104 | $37.55 | $79.0k | [Form 4](/filings/0001395064-21-000105.md) |
| 2021-05-28 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 2,668 | $36.40 | $97.1k | [Form 4](/filings/0001395064-21-000105.md) |
| 2021-05-28 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 4,133 | $35.37 | $146.2k | [Form 4](/filings/0001395064-21-000105.md) |
| 2021-05-27 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 2,279 | $37.55 | $85.6k | [Form 4](/filings/0001395064-21-000103.md) |
| 2021-05-27 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 6,174 | $36.99 | $228.4k | [Form 4](/filings/0001395064-21-000103.md) |
| 2021-05-26 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 4,889 | $36.92 | $180.5k | [Form 4](/filings/0001395064-21-000103.md) |
| 2021-05-26 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 7,469 | $36.45 | $272.2k | [Form 4](/filings/0001395064-21-000103.md) |
| 2021-05-25 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 548 | $36.59 | $20.1k | [Form 4](/filings/0001395064-21-000089.md) |
| 2021-05-25 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 10,399 | $36.16 | $376.0k | [Form 4](/filings/0001395064-21-000089.md) |
| 2021-05-24 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 1,683 | $36.10 | $60.8k | [Form 4](/filings/0001395064-21-000089.md) |
| 2021-05-24 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 8,911 | $35.58 | $317.1k | [Form 4](/filings/0001395064-21-000089.md) |
| 2021-05-21 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 11,648 | $35.74 | $416.3k | [Form 4](/filings/0001395064-21-000087.md) |
| 2021-05-20 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 7,098 | $35.10 | $249.1k | [Form 4](/filings/0001395064-21-000087.md) |
| 2021-05-14 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 100 | $35.00 | $3.5k | [Form 4](/filings/0001395064-21-000082.md) |
| 2021-05-13 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 100 | $35.33 | $3.5k | [Form 4](/filings/0001395064-21-000078.md) |
| 2021-05-12 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 905 | $36.06 | $32.6k | [Form 4](/filings/0001395064-21-000078.md) |
| 2021-05-12 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 10,871 | $35.39 | $384.7k | [Form 4](/filings/0001395064-21-000078.md) |
| 2021-05-07 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 1,011 | $35.03 | $35.4k | [Form 4](/filings/0001395064-21-000076.md) |
| 2021-05-06 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 202 | $35.01 | $7.1k | [Form 4](/filings/0001395064-21-000060.md) |
| 2021-05-05 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 6,936 | $35.14 | $243.7k | [Form 4](/filings/0001395064-21-000060.md) |
| 2021-05-04 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 100 | $38.53 | $3.9k | [Form 4](/filings/0001395064-21-000058.md) |
| 2021-05-04 | [Phathom Pharmaceuticals, Inc.](/companies/phat.md) | Sale (S) | 3,500 | $37.47 | $131.1k | [Form 4](/filings/0001395064-21-000058.md) |

Page 1 of 2. [Older](/insiders/1395064.md?page=2)
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 31, 2026, 07:24 ET. No prices; not investment advice.